PRMT5

Haoyang Wu1,2, Peiyuan Lv1,2, Jinyu Wang1,2

  • 1Department of Neurology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.

eLife
|February 19, 2024
PubMed
概括

研究人员确定PRMT5是继缺血性中风后神经元存活的新型负调节剂. 抑制PRMT5在细胞和动物模型中表现出神经保护作用,揭示了中风的新治疗点.